Blood
Review of recombinant clotting factor technology — laboratory-manufactured alternatives to plasma-derived factors. Important distinction for patients: recombinant factors are not derived from donated blood, offering a non-blood-derived option for hemophilia management and surgical hemostasis.
Recombinant clotting factors are produced using genetic engineering technology without the use of human blood or plasma, eliminating the risk of blood-borne pathogen transmission.